Figure 1From: Successful use of eculizumab in an 86-year-old patient with paroxysmal nocturnal hemoglobinuria in JapanFlow cytometry of red blood cells. A-1: CD55 (pre-eculizumab). A-2: CD59 (pre-eculizumab). B: CD55/CD59 (post-eculizumab).Back to article page